ArticleMedicina (Kaunas, Lithuania)2024

Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression.

Walid Shalata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.